[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630230":3},{"organization":4,"outcomesModule":7,"designInfo":77,"detailedDescription":79,"studyPopulation":80,"armGroups":76,"interventions":76,"overallOfficials":76,"centralContacts":81,"locations":87,"responsibleParty":339,"collaborators":341,"id":350,"slug":351,"hasResults":352,"nctId":353,"briefTitle":354,"officialTitle":354,"acronym":355,"eligibilityCriteria":356,"healthyVolunteers":352,"sex":357,"minAge":358,"maxAge":76,"enrollmentInfo":359,"targetDuration":76,"studyType":362,"phases":76,"briefSummary":363,"conditions":364,"keywords":371,"overallStatus":116,"whyStopped":76,"lastUpdateSubmitDate":385,"lastUpdatePostDateStruct":386,"startDateStruct":389,"completionDateStruct":391,"leadSponsor":393,"locationsCount":394},{"fullName":5,"class":6},"Société Algérienne de Formation et Recherche en Oncologie","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":36,"otherOutcomes":76},[9,13,17,21,24,27,30,33],{"measure":10,"description":11,"timeFrame":12},"Socio-demographic characteristics of patients with prostate cancer in Algeria","Frequency (%) of sociodemographic characteristics of patients with prostate cancer in Algeria, including age at diagnosis, marital status, and socioeconomic level.","At Baseline ( Initial visit )",{"measure":14,"description":15,"timeFrame":16},"Personal and family history of cancer","Frequency (%) of patients with personal and family history of cancer.","At Baseline (Initial Visit)",{"measure":18,"description":19,"timeFrame":20},"Environmental and occupational exposures","Frequency (%) of patients with environmental or occupational exposures.","At Baseline (Initial visit)",{"measure":22,"description":23,"timeFrame":20},"Smoking history","Frequency (%) of patients according to smoking status (current, former, never).",{"measure":25,"description":26,"timeFrame":20},"Alcohol consumption","Frequency (%) of patients according to alcohol consumption (yes\u002Fno).",{"measure":28,"description":29,"timeFrame":20},"Initial symptoms and circumstances of diagnosis","Frequency (%) of patients according to type of initial symptoms and circumstances of diagnosis.",{"measure":31,"description":32,"timeFrame":20},"International Prostate Symptom Score (IPSS)","Distribution of patients according to the International Prostate Symptom Score (IPSS) at baseline. The IPSS is a validated questionnaire assessing the severity of lower urinary tract symptoms, with a total score ranging from 0 to 35, where higher scores indicate more severe (worse) symptoms.",{"measure":34,"description":35,"timeFrame":20},"Evolutionary status of patients","Frequency (%) of patients according to disease status (in remission or with disease progression).",[37,40,43,46,49,52,55,58,61,64,67,70,73],{"measure":38,"description":39,"timeFrame":20},"Diagnosis by PSA testing","% of patients diagnosed by PSA testing.",{"measure":41,"description":42,"timeFrame":20},"Diagnosis by imaging","% of patients diagnosed by imaging.",{"measure":44,"description":45,"timeFrame":20},"Diagnosis by biopsy","% of patients diagnosed by biopsy.",{"measure":47,"description":48,"timeFrame":20},"Time from symptom onset to first medical consultation","Median time (in days) between onset of first symptoms and first medical consultation.",{"measure":50,"description":51,"timeFrame":20},"Time from first consultation to confirmed diagnosis","Median time (in days) between first medical consultation and confirmed diagnosis.",{"measure":53,"description":54,"timeFrame":20},"Patients discussed in multidisciplinary team meetings","% of patients discussed in tumor boards \u002F multidisciplinary team meetings.",{"measure":56,"description":57,"timeFrame":20},"Initial treatment: Surgery","% of patients receiving surgery as initial treatment.",{"measure":59,"description":60,"timeFrame":20},"Initial treatment: Radiotherapy","% of patients receiving radiotherapy as initial treatment.",{"measure":62,"description":63,"timeFrame":20},"Initial treatment: Hormone therapy","% of patients receiving hormone therapy as initial treatment.",{"measure":65,"description":66,"timeFrame":20},"Initial treatment: Active surveillance","% of patients under active surveillance as initial management.",{"measure":68,"description":69,"timeFrame":20},"Time from diagnosis to treatment initiation","Median time (in days) between diagnosis and treatment initiation.",{"measure":71,"description":72,"timeFrame":20},"Specialty of physician initiating treatment","Medical specialty of the physician initiating treatment (urologist, oncologist, etc.).",{"measure":74,"description":75,"timeFrame":20},"Adverse events","Frequency of adverse events by system\u002Forgan class and distribution according to severity grades (CTCAE grades 1 to 5).",null,{"allocation":76,"interventionModel":76,"interventionModelDescription":76,"primaryPurpose":76,"observationalModel":6,"timePerspective":78,"maskingInfo":76},"CROSS_SECTIONAL","This is a descriptive, cross-sectional clinical study including patients with histologically and\u002For biologically confirmed prostate cancer who are being followed in the participating centers. This study planned to enroll 500 patients.\n\nData will be collected from medical records and structured patient interviews (≈30 minutes). A standardized electronic case report form (eCRF) will be used to ensure completeness and reliability of the data. The variables studied will include sociodemographic data, medical history, clinical and biological characteristics of the disease, diagnostic examinations performed, and the therapeutic strategies implemented. All information will be anonymized and used exclusively for research purposes.","Patients with histologically and\u002For biologically confirmed prostate cancer, followed in the participating centers.",[82],{"name":83,"role":84,"phone":85,"phoneExt":76,"email":86},"BOUNEDJAR ADDA, Professor","CONTACT","+213 25 20 90 72","a_bounedjar@yahoo.fr",[88,106,114,127,136,144,153,162,171,184,192,200,212,220,233,241,254,267,275,284,292,305,313,326],{"facility":89,"status":90,"city":91,"state":92,"zip":93,"country":92,"countryCode":94,"cosmosGeoPoint":95,"geoPoint":100,"contacts":101},"CAC Adrar - Oncology Department","NOT_YET_RECRUITING","Adrar","Algeria","01000","DZ",{"type":96,"coordinates":97},"Point",[98,99],-0.29388,27.87429,{"lat":99,"lon":98},[102],{"name":103,"role":84,"phone":104,"phoneExt":76,"email":105},"KOUIDER KHADIDJA, Professor","+213 49 36 89 00","contact@esclinicalresearch.com",{"facility":107,"status":90,"city":91,"state":92,"zip":93,"country":92,"countryCode":94,"cosmosGeoPoint":108,"geoPoint":110,"contacts":111},"CAC Adrar - Radiotherapy Department",{"type":96,"coordinates":109},[98,99],{"lat":99,"lon":98},[112],{"name":113,"role":84,"phone":104,"phoneExt":76,"email":105},"FELLAG Houmem, Doctor",{"facility":115,"status":116,"city":117,"state":92,"zip":118,"country":92,"countryCode":94,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"CAC BLIDA - Oncology Department","RECRUITING","Algiers","16000",{"type":96,"coordinates":120},[121,122],3.08746,36.73225,{"lat":122,"lon":121},[125],{"name":126,"role":84,"phone":85,"phoneExt":76,"email":105},"BOUNEDJAR Adda, Professor",{"facility":128,"status":116,"city":117,"state":92,"zip":118,"country":92,"countryCode":94,"cosmosGeoPoint":129,"geoPoint":131,"contacts":132},"Centre Pierre et Marie Curie - Oncology Department",{"type":96,"coordinates":130},[121,122],{"lat":122,"lon":121},[133],{"name":134,"role":84,"phone":135,"phoneExt":76,"email":105},"KEBOUA ESMA, Professor","+213 23 55 96 80",{"facility":137,"status":116,"city":117,"state":92,"zip":118,"country":92,"countryCode":94,"cosmosGeoPoint":138,"geoPoint":140,"contacts":141},"Centre Pierre et Marie Curie - Radiology Department",{"type":96,"coordinates":139},[121,122],{"lat":122,"lon":121},[142],{"name":143,"role":84,"phone":135,"phoneExt":76,"email":105},"OUKRIF Séam, Professor",{"facility":145,"status":116,"city":117,"state":92,"zip":118,"country":92,"countryCode":94,"cosmosGeoPoint":146,"geoPoint":148,"contacts":149},"CHU Bab El Oued",{"type":96,"coordinates":147},[121,122],{"lat":122,"lon":121},[150],{"name":151,"role":84,"phone":152,"phoneExt":76,"email":105},"BELKACEM-NACER Abdelwahab, Professor","+213 21 96 06 06",{"facility":154,"status":116,"city":117,"state":92,"zip":118,"country":92,"countryCode":94,"cosmosGeoPoint":155,"geoPoint":157,"contacts":158},"CHU Béni Messous - Oncology Departement",{"type":96,"coordinates":156},[121,122],{"lat":122,"lon":121},[159],{"name":160,"role":84,"phone":161,"phoneExt":76,"email":105},"Oukkal Mohammed, Professor","+213 219 311 90",{"facility":163,"status":116,"city":117,"state":92,"zip":118,"country":92,"countryCode":94,"cosmosGeoPoint":164,"geoPoint":166,"contacts":167},"EPH ROUIBA - Oncology Department",{"type":96,"coordinates":165},[121,122],{"lat":122,"lon":121},[168],{"name":169,"role":84,"phone":170,"phoneExt":76,"email":105},"MAHFOUF Hassen, Professor","+213 21 86 04 35",{"facility":172,"status":116,"city":173,"state":92,"zip":174,"country":92,"countryCode":94,"cosmosGeoPoint":175,"geoPoint":179,"contacts":180},"CAC Annaba - Oncology Departement","Annaba","23000",{"type":96,"coordinates":176},[177,178],7.76667,36.9,{"lat":178,"lon":177},[181],{"name":182,"role":84,"phone":183,"phoneExt":76,"email":105},"DJEDDI Hanene, Professor","+213 38 40 00 04",{"facility":185,"status":116,"city":173,"state":92,"zip":174,"country":92,"countryCode":94,"cosmosGeoPoint":186,"geoPoint":188,"contacts":189},"CAC Annaba - Radiotherapy Department",{"type":96,"coordinates":187},[177,178],{"lat":178,"lon":177},[190],{"name":191,"role":84,"phone":183,"phoneExt":76,"email":105},"NAOUN Lilia, Professor",{"facility":193,"status":116,"city":173,"state":92,"zip":174,"country":92,"countryCode":94,"cosmosGeoPoint":194,"geoPoint":196,"contacts":197},"CAC Annaba - Urology Departement",{"type":96,"coordinates":195},[177,178],{"lat":178,"lon":177},[198],{"name":199,"role":84,"phone":183,"phoneExt":76,"email":105},"CHETTIBI kheireddine, Professor",{"facility":201,"status":116,"city":202,"state":92,"zip":203,"country":92,"countryCode":94,"cosmosGeoPoint":204,"geoPoint":208,"contacts":209},"CAC Bida - Radiotherapy Department","Blida","09000",{"type":96,"coordinates":205},[206,207],2.8277,36.47004,{"lat":207,"lon":206},[210],{"name":211,"role":84,"phone":85,"phoneExt":76,"email":105},"HAOUI Messaouda, Professor",{"facility":213,"status":116,"city":202,"state":92,"zip":203,"country":92,"countryCode":94,"cosmosGeoPoint":214,"geoPoint":216,"contacts":217},"CAC BLIDA - Urology Department",{"type":96,"coordinates":215},[206,207],{"lat":207,"lon":206},[218],{"name":219,"role":84,"phone":85,"phoneExt":76,"email":105},"OULD ARBI Sid Ahmed, Professor",{"facility":221,"status":116,"city":222,"state":92,"zip":223,"country":92,"countryCode":94,"cosmosGeoPoint":224,"geoPoint":228,"contacts":229},"CHU Constantine - Oncology Departement","Constantine","25000",{"type":96,"coordinates":225},[226,227],6.61472,36.365,{"lat":227,"lon":226},[230],{"name":231,"role":84,"phone":232,"phoneExt":76,"email":105},"ZERROUK DALAL, Professor","+213 31 88 66 22",{"facility":234,"status":116,"city":222,"state":92,"zip":223,"country":92,"countryCode":94,"cosmosGeoPoint":235,"geoPoint":237,"contacts":238},"EH Constantine - Oncology Departement",{"type":96,"coordinates":236},[226,227],{"lat":227,"lon":226},[239],{"name":240,"role":84,"phone":232,"phoneExt":76,"email":105},"BENSALEM Assia, Professor",{"facility":242,"status":116,"city":243,"state":92,"zip":244,"country":92,"countryCode":94,"cosmosGeoPoint":245,"geoPoint":249,"contacts":250},"EPH Mostaghanem - Oncology Department","Mostaganem","27000",{"type":96,"coordinates":246},[247,248],0.08918,35.93115,{"lat":248,"lon":247},[251],{"name":252,"role":84,"phone":253,"phoneExt":76,"email":105},"ZIDANE Habib, Professor","+213 45 41 09 49",{"facility":255,"status":116,"city":256,"state":92,"zip":257,"country":92,"countryCode":94,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"CAC ORAN - Oncology Department","Oran","31000",{"type":96,"coordinates":259},[260,261],-0.63588,35.69906,{"lat":261,"lon":260},[264],{"name":265,"role":84,"phone":266,"phoneExt":76,"email":105},"LARBAOUI Blaha, Professor","+213 20 33 91 20",{"facility":268,"status":116,"city":256,"state":92,"zip":257,"country":92,"countryCode":94,"cosmosGeoPoint":269,"geoPoint":271,"contacts":272},"CAC ORAN - Radiotherapy Department",{"type":96,"coordinates":270},[260,261],{"lat":261,"lon":260},[273],{"name":274,"role":84,"phone":266,"phoneExt":76,"email":105},"BOUKERCHE Abdelbaki, Professor",{"facility":276,"status":90,"city":256,"state":92,"zip":257,"country":92,"countryCode":94,"cosmosGeoPoint":277,"geoPoint":279,"contacts":280},"EHU ORAN - Oncology Department",{"type":96,"coordinates":278},[260,261],{"lat":261,"lon":260},[281],{"name":282,"role":84,"phone":283,"phoneExt":76,"email":105},"BEREKSI REGUIG FAIZA, Professor","+213 41 70 50 92",{"facility":285,"status":116,"city":256,"state":92,"zip":257,"country":92,"countryCode":94,"cosmosGeoPoint":286,"geoPoint":288,"contacts":289},"EHU ORAN - Urology Department",{"type":96,"coordinates":287},[260,261],{"lat":261,"lon":260},[290],{"name":291,"role":84,"phone":283,"phoneExt":76,"email":105},"YOUSFI Mostafa Jamel, Professor",{"facility":293,"status":116,"city":294,"state":92,"zip":295,"country":92,"countryCode":94,"cosmosGeoPoint":296,"geoPoint":300,"contacts":301},"CAC Sétif - Oncology Departement","Sétif","19000",{"type":96,"coordinates":297},[298,299],5.41373,36.19112,{"lat":299,"lon":298},[302],{"name":303,"role":84,"phone":304,"phoneExt":76,"email":105},"DIB Adlane Husseine, Professor","+213 36 45 45 45",{"facility":306,"status":116,"city":294,"state":92,"zip":295,"country":92,"countryCode":94,"cosmosGeoPoint":307,"geoPoint":309,"contacts":310},"CAC Sétif - Radiotherapy Department",{"type":96,"coordinates":308},[298,299],{"lat":299,"lon":298},[311],{"name":312,"role":84,"phone":304,"phoneExt":76,"email":105},"BOUDAOUD Khadidja, Professor",{"facility":314,"status":116,"city":315,"state":92,"zip":316,"country":92,"countryCode":94,"cosmosGeoPoint":317,"geoPoint":321,"contacts":322},"EPH Sidi Ghilès - Oncology Department","Tipasa","42000",{"type":96,"coordinates":318},[319,320],2.44889,36.58972,{"lat":320,"lon":319},[323],{"name":324,"role":84,"phone":325,"phoneExt":76,"email":105},"SEGHIER Fatma, Professor","+213 24 33 12 25",{"facility":327,"status":116,"city":328,"state":92,"zip":329,"country":92,"countryCode":94,"cosmosGeoPoint":330,"geoPoint":334,"contacts":335},"CAC Draa Ben Khedda - Radiotherapy Departement","Tizi Ouzou","15000",{"type":96,"coordinates":331},[332,333],4.04591,36.71182,{"lat":333,"lon":332},[336],{"name":337,"role":84,"phone":338,"phoneExt":76,"email":105},"BENZIDANE Kahina, Professor","+213 549 30 70 71",{"type":340,"investigatorFullName":76,"investigatorTitle":76,"investigatorAffiliation":76,"oldNameTitle":76,"oldOrganization":76},"SPONSOR",[342,345,348],{"name":343,"class":344},"ES Clinical Research","UNKNOWN",{"name":346,"class":347},"Ipsen","INDUSTRY",{"name":349,"class":347},"Astellas Pharma Inc","100630230","study-of-the-epidemiological-clinical-diagnostic-and-therapeutic-characteristics-of-prostate-cancers-in-algeria-100630230",false,"NCT07484971","Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria","CLIQQC","Inclusion Criteria:\n\n* Patients aged 19 years and older.\n* Diagnosis of prostate cancer confirmed histologically and\u002For biologically.\n* Patients followed in the participating oncology departments.\n* Written informed consent obtained.\n\nNon Inclusion Criteria:\n\n* Histological types other than carcinoma\n* Secondary tumors\n* Participation in an interventional study","MALE","19 Years",{"count":360,"type":361},2000,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer.\n\nIt also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.",[365,366,367,368,369,370],"Prostate Cancer","Prostate Cancer (Diagnosis)","Prostate Cancer (Post Prostatectomy)","Prostate Cancer Patients Treated by Radiotherapy","Prostate Cancer Metastatic","Prostate Cancer (Adenocarcinoma)",[372,373,365,374,375,376,377,378,379,380,381,382,383,92,384],"oncology","patient outcome","Prostate Cancer in Algerian patients","Observational Study","Retrospective data","Treatment strategies","Diagnostic approaches","Clinical characteristics","Epidemiological data","Demographic data","Cross-sectional study","Real-world data","Algerian Study","2026-04-14",{"date":387,"type":388},"2026-04-17","ACTUAL",{"date":390,"type":388},"2025-07-21",{"date":392,"type":361},"2026-07-21",{"name":5,"class":6},24]